News | May 19, 2023
Gland Pharma posts Q4 FY23 consolidated PAT at Rs. 78.68 Cr
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
Gland Pharma has reported total income of Rs. 823.95 crores during the period ended March 31, 2023
These initiatives aim to improve access to healthcare for rare disease patients
Late-breaking data from DCR4Contrast study presented at EuroPCR 2023 and SCAI 2023 also shows an average reduction in the total number of angiograms obtained during each procedure of 26.3%
Farxiga is expected to have such a strong influence on the market due to the impressive results
The Niti Aayog and the DoP had listed a few factors that were leading to a 10-15% disability factor to be globally competitive
To enhance housing and enclosure design and performance for the Asia Pacific medical devices market, Kraiburg TPE offers the Thermoplast H HC/AP and HC/AD1/AP series
The company has reported total income of Rs. 149.78 crores during the period ended March 31, 2023
The addition of these two hospitals will provide increased access to specialized pediatric and perinatal care services in the geography
Dr. Reddy's Laboratories has been issued a Form 483 with four observations
The facility will have a capacity to manufacture upto 3 million tubes monthly
Subscribe To Our Newsletter & Stay Updated
